Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1382-05

Staarvisc II Sodium Hyaluronate 0.8 mL 12mg/mL Syringe. Sterile. Rx. For intraocular use. P/N490-001...

Anika Therapeutics, Inc. / initiated 2005-07-14 / Terminated / root cause: packaging

Anika Therapeutics, Inc. began a recall of Staarvisc II Sodium Hyaluronate 0.8 mL 12mg/mL Syringe. Sterile. Rx. For intraocular use. P/N490-001 Distributed by: STAAR Surgical Inc., Monrovia CA on . The reason FDA records is "Product sterility may be compromised due incomplete heat seals in the cannula pouches that are included with the viscoelastic syringe". As of , the recall status on record is Terminated, and MDM tags the root cause as packaging.

Recall record

Recall number
Z-1382-05
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Anika Therapeutics, Inc.
Product
Staarvisc II Sodium Hyaluronate 0.8 mL 12mg/mL Syringe. Sterile. Rx. For intraocular use. P/N490-001 Distributed by: STAAR Surgical Inc., Monrovia CA
Product code
LZP Aid, Surgical, Viscoelastic
Reason for recall
Product sterility may be compromised due incomplete heat seals in the cannula pouches that are included with the viscoelastic syringe.
Root cause tag
packaging
FDA root cause
Other
Action
Anika Therapeutics notified Distributor accounts by telephone on July 14. The letters were faxed and sent by Fedex on July 14. Distributors were provided with a end-user letter template letter for notification to their accounts.
Quantity in commerce
20,549 units
Distribution
CA, NC
Product codes and lots
Lot Numbers: B041118C, B050510A